Navigation Links
Audet & Partners, LLP Files First Raptiva Lawsuit After Announced Withdrawal

Audet & Partners, LLP, a San Francisco, California-based trial law firm, filed the first complaint against Genentech arising out of the recently announced withdrawal of Raptiva medication. Filed in Alameda Superior Court, the complaint seeks general and punitive damages.

San Francisco, CA (PRWEB) April 9, 2009 -- Audet & Partners, LLP, a San Francisco, California-based trial law firm, filed the first complaint against Genentech arising out of the recently announced withdrawal of Raptiva medication. Filed in Alameda Superior Court (Case #rg09-446158), the complaint seeks general and punitive damages.

Raptiva is a medication used to treat severe to moderate psoriasis and works by suppressing the immune system. According to allegations in the complaint filed by Audet & Partners, LLP Raptiva allegedly causes a number of serious life-threatening infections, including encephalitis, viral meningitis and a rare brain infection known as progressive multifocal leukoencephalopathy (PML). At least three and possibly four cases of PML brain infections have been confirmed by the FDA.

Due to safety concerns, Raptiva already is suspended from the market in both Europe and Canada, and as of April 8, 2009, Genentech announced a phased withdrawal of Raptiva from the United States market.

"We have a number of clients who have contacted our firm over the past couple of months regarding Raptiva, and this is one of the first cases filed in the United States," noted William M. Audet, managing partner of Audet & Partners, LLP, "We expect that more cases will be filed by our firm as our investigation continues."

In the complaint, Plaintiff Mary Hedrick alleges that she suffered herpes viral encephalitis, a rare brain infection, as a result of being treated with Raptiva. This left her with permanent brain and nervous system damage requiring her to undergo intensive rehabilitation to relearn how to walk and speak. Plaintiff Shirley Boxell is suing on behalf of her daughter, Megan, who died of a brain infection at age 26, after taking Raptiva for one year. Plaintiff Bruce Harwell has suffered from severe leucopenia, as well as other injuries, allegedly due to Raptiva.

"All of the plaintiffs in this case have suffered serious injury while taking Raptiva, a monoclonal antibody that inhibits T-cell activity," stated Susanne Scovern, a trial attorney at Audet & Partners, LLP. "No one would choose to take a life-threatening drug for a non-life-threatening injury. The dangerous side effects of Raptiva far outweighed the good it did to treat psoriasis," she stated.

Audet & Partners, LLP, (221 Main Street, Suite 1460, San Francisco, CA 94105, 415.982.1776) a San Francisco-based law firm, represents individuals, governmental entities, small businesses and shareholders in product liability, tort, negligence, consumer, construction defect, investment fraud, securities, insider trading, antitrust, environmental, whistle blower, aviation and employment cases. The founding partner, William M. Audet, has served as court-approved lead counsel in dozens of federal and state cases throughout the United States.

# # #

Read the full story at

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related medicine news :

1. Get Your Fruits & Veggies: CDC
2. Mount Sinai & ENT and Allergy Associates, LLP affiliate to fight cancer
3. Story ideas from molecular & cellular proteomics
4. Job picture for 2006 chemistry grads reasonably good, C&EN reports
5. Debut issue of Foot & Ankle Specialist
6. Congressional R&D Caucus co-chairs join scientists, engineers and graduate students
7. IU Health & Wellness: Research and insights from Indiana University
8. Genetic Engineering & Biotechnology News reports on clinical trials in developing countries
9. European Society of Human Reproduction & Embryology 24th annual meeting
10. IU Health & Wellness: New research findings from the Kinsey Institute
11. Riley Hospital for Children & Capital Institute of Pediatrics become international sister hospitals
Post Your Comments:
(Date:11/25/2015)... ... November 25, 2015 , ... ... lower prices in an early celebration of the early holiday shopping season. Starting ... $29.95 each (normally $33.95 ea). Black Friday promotional pricing is in addition to ...
(Date:11/24/2015)... PA (PRWEB) , ... November 24, 2015 , ... ... now certified to offer their patients the many benefits of the revolutionary BIOLASE ... the sharp cutting and scraping tools traditionally used by a dentist in ...
(Date:11/24/2015)... ... November 24, 2015 , ... New patients who wish to seek treatment ... dental implants at her Mississauga, ON practice. Dr. Williams has been providing dental ... dental implants. , Missing teeth can lead to a variety of complications if ...
(Date:11/24/2015)... , ... November 24, 2015 , ... Charitable giving is ... donations are made in the last five weeks of the year totalling over $358 ... in 2012 to connect the nation’s charities with those individuals who want to “give ...
(Date:11/24/2015)... , ... November 24, 2015 , ... In an ... restrictions and variables that determine which patients are or are not eligible for bariatric ... have a BMI over 40, are more than 100 pounds overweight, or have a ...
Breaking Medicine News(10 mins):
(Date:11/24/2015)... Nov. 24, 2015  In the pharmaceutical industry, companies ... effort to quickly uncover new insights, tactics and strategies ... --> --> However, organizations often find ... project and ensure that all rules and regulations are ... Another major barrier to efficiently launching market research projects ...
(Date:11/24/2015)... NEWPORT NEWS, Va. , Nov. 24, 2015 /PRNewswire/ ... that they have signed an agreement for DILON to ... select geographies across the globe. The signing of this distribution ... GE,s Discovery NM750b Molecular Breast Imaging system and is ... ways to provide better healthcare solutions for clinicians and ...
(Date:11/24/2015)... Nov. 24, 2015   HeartWare International, Inc . ... miniaturized circulatory support technologies that are revolutionizing the treatment ... Chief Executive Officer Doug Godshall is scheduled ... Annual Healthcare Conference on December 1, 2015 at 3:00 ... in New York . ...
Breaking Medicine Technology: